MARKET

QURE

QURE

Uniqure
NASDAQ

Real-time Quotes | Nasdaq Last Sale

50.48
+2.67
+5.58%
After Hours: 50.48 0 0.00% 16:35 04/07 EDT
OPEN
48.97
PREV CLOSE
47.81
HIGH
52.26
LOW
47.92
VOLUME
548.51K
TURNOVER
--
52 WEEK HIGH
82.49
52 WEEK LOW
36.20
MARKET CAP
2.23B
P/E (TTM)
-16.3149
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 18 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average QURE stock price target is 85.81 with a high estimate of 105.00 and a low estimate of 73.00.

EPS

QURE News

More
  • uniQure (QURE) Investor Presentation - Slideshow
  • Seeking Alpha - Article · 7h ago
  • FDA OKs new hemophilia treatment
  • Seeking Alpha - Article · 6d ago
  • uniQure to Participate in Multiple Upcoming Investor Conferences in April
  • GlobeNewswire · 03/30 12:00
  • Hedge Funds Have Never Been This Bullish On Uniqure NV (QURE)
  • Insider Monkey · 03/29 01:10

Industry

Biotechnology & Medical Research
-2.20%
Pharmaceuticals & Medical Research
-1.62%

Hot Stocks

Symbol
Price
%Change

About QURE

Uniqure NV is a company based in the Netherlands specialized in gene therapy. It seeks to develop one-time administered treatments with potentially curative results for patients suffering from genetic and other devastating diseases. It develops, both internally and through partnerships, a pipeline of gene therapies. It produces adeno-associated virus based, or AAV-based, gene therapies in its own facilities with a proprietary, commercial-scale, current good manufacturing practices, compliant, manufacturing process. AMT-061, the Company’s lead product candidate for patients with hemophilia B, is going through a dosing phase of a pivotal study. AMT-130, the product candidate for patients with Huntington’s disease is in Phase I/II clinical study.
More

Webull offers kinds of Uniqure NV stock information, including NASDAQ:QURE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QURE stock news, and many more online research tools to help you make informed decisions.